These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

603 related articles for article (PubMed ID: 17611637)

  • 1. Systemic and local levels of fetuin-A in calcific aortic valve stenosis.
    Kaden JJ; Reinöhl JO; Blesch B; Brueckmann M; Haghi D; Borggrefe M; Schmitz F; Klomfass S; Pillich M; Ortlepp JR
    Int J Mol Med; 2007 Aug; 20(2):193-7. PubMed ID: 17611637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lower serum calcium levels are associated with greater calcium hydroxyapatite deposition in native aortic valves of male patients with severe calcific aortic stenosis.
    Ortlepp JR; Pillich M; Schmitz F; Mevissen V; Koos R; Weiss S; Stork L; Dronskowski R; Langebartels G; Autschbach R; Brandenburg V; Woodruff S; Kaden JJ; Hoffmann R
    J Heart Valve Dis; 2006 Jul; 15(4):502-8. PubMed ID: 16901043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of bone sialoprotein and bone morphogenetic protein-2 in calcific aortic stenosis.
    Kaden JJ; Bickelhaupt S; Grobholz R; Vahl CF; Hagl S; Brueckmann M; Haase KK; Dempfle CE; Borggrefe M
    J Heart Valve Dis; 2004 Jul; 13(4):560-6. PubMed ID: 15311861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcription factor Egr-1 in calcific aortic valve disease.
    Ghazvini-Boroujerdi M; Clark J; Narula N; Palmatory E; Connolly JM; DeFelice S; Xu J; Jian B; Hazelwood S; Levy RJ
    J Heart Valve Dis; 2004 Nov; 13(6):894-903. PubMed ID: 15597579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory regulation of extracellular matrix remodeling in calcific aortic valve stenosis.
    Kaden JJ; Dempfle CE; Grobholz R; Fischer CS; Vocke DC; Kiliç R; Sarikoç A; Piñol R; Hagl S; Lang S; Brueckmann M; Borggrefe M
    Cardiovasc Pathol; 2005; 14(2):80-7. PubMed ID: 15780799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenetic role of Chlamydia pneumoniae in calcific aortic stenosis: immunohistochemistry study and review of the literature.
    Kaden JJ; Bickelhaupt S; Grobholz R; Brueckmann M; Haase KK; Dempfle CE; Borggrefe M
    J Heart Valve Dis; 2003 Jul; 12(4):447-53. PubMed ID: 12918845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum gamma-glutamyltransferase activity is increased in patients with calcific aortic valve stenosis.
    Bozbas H; Yildirir A; Demir O; Cakmak A; Karacaglar E; Yilmaz M; Eroglu S; Pirat B; Ozin B; Muderrisoglu H
    J Heart Valve Dis; 2008 Jul; 17(4):371-5. PubMed ID: 18751465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic and local levels of fetuin-a in calcified mitral valves of rheumatic heart disease.
    Mukhopadhyay S; Pandit BN; Saran RK; Mazumdar K; Yusuf J; Minhas HS; Trehan V; Tyagi S
    J Heart Valve Dis; 2014 Jan; 23(1):55-65. PubMed ID: 24779329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor necrosis factor-α accelerates the calcification of human aortic valve interstitial cells obtained from patients with calcific aortic valve stenosis via the BMP2-Dlx5 pathway.
    Yu Z; Seya K; Daitoku K; Motomura S; Fukuda I; Furukawa K
    J Pharmacol Exp Ther; 2011 Apr; 337(1):16-23. PubMed ID: 21205918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-18 is involved in vascular injury in end-stage renal disease patients.
    Porazko T; Kúzniar J; Kusztal M; Kúzniar TJ; Weyde W; Kuriata-Kordek M; Klinger M
    Nephrol Dial Transplant; 2009 Feb; 24(2):589-96. PubMed ID: 18775894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noncollagenous bone matrix proteins as a part of calcific aortic valve disease regulation.
    Pohjolainen V; Taskinen P; Soini Y; Rysä J; Ilves M; Juvonen T; Ruskoaho H; Leskinen H; Satta J
    Hum Pathol; 2008 Nov; 39(11):1695-701. PubMed ID: 18701137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical factors, but not C-reactive protein, predict progression of calcific aortic-valve disease: the Cardiovascular Health Study.
    Novaro GM; Katz R; Aviles RJ; Gottdiener JS; Cushman M; Psaty BM; Otto CM; Griffin BP
    J Am Coll Cardiol; 2007 Nov; 50(20):1992-8. PubMed ID: 17996566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential profile of the OPG/RANKL/RANK-system in degenerative aortic native and bioprosthetic valves.
    Steinmetz M; Skowasch D; Wernert N; Welsch U; Preusse CJ; Welz A; Nickenig G; Bauriedel G
    J Heart Valve Dis; 2008 Mar; 17(2):187-93. PubMed ID: 18512489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and activity of matrix metalloproteinase-2 in calcific aortic stenosis.
    Kaden JJ; Vocke DC; Fischer CS; Grobholz R; Brueckmann M; Vahl CF; Hagl S; Haase KK; Dempfle CE; Borggrefe M
    Z Kardiol; 2004 Feb; 93(2):124-30. PubMed ID: 14963678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone regulatory factors NFATc1 and Osterix in human calcific aortic valves.
    Alexopoulos A; Bravou V; Peroukides S; Kaklamanis L; Varakis J; Alexopoulos D; Papadaki H
    Int J Cardiol; 2010 Mar; 139(2):142-9. PubMed ID: 19019468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Refining molecular pathways leading to calcific aortic valve stenosis by studying gene expression profile of normal and calcified stenotic human aortic valves.
    Bossé Y; Miqdad A; Fournier D; Pépin A; Pibarot P; Mathieu P
    Circ Cardiovasc Genet; 2009 Oct; 2(5):489-98. PubMed ID: 20031625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between circulating oxidised low-density lipoprotein and fibrocalcific remodelling of the aortic valve in aortic stenosis.
    Côté C; Pibarot P; Després JP; Mohty D; Cartier A; Arsenault BJ; Couture C; Mathieu P
    Heart; 2008 Sep; 94(9):1175-80. PubMed ID: 17932090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of fetuin-A levels with the progression of aortic valve calcification in non-dialyzed patients.
    Koos R; Brandenburg V; Mahnken AH; Mühlenbruch G; Stanzel S; Günther RW; Floege J; Jahnen-Dechent W; Kelm M; Kühl HP
    Eur Heart J; 2009 Aug; 30(16):2054-61. PubMed ID: 19429630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between self-replicating calcifying nanoparticles and aortic stenosis: a possible link to valve calcification.
    Bratos-Pérez MA; Sánchez PL; García de Cruz S; Villacorta E; Palacios IF; Fernández-Fernández JM; Di Stefano S; Orduña-Domingo A; Carrascal Y; Mota P; Martín-Luengo C; Bermejo J; San Roman JA; Rodríguez-Torres A; Fernández-Avilés F;
    Eur Heart J; 2008 Feb; 29(3):371-6. PubMed ID: 18192703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Could activated tissue remodeling be considered as early marker for progressive valve degeneration? Comparative analysis of checkpoint and ECM remodeling gene expression in native degenerating aortic valves and after bioprosthetic replacement.
    Yeghiazaryan K; Skowasch D; Bauriedel G; Schild H; Golubnitschaja O
    Amino Acids; 2007 Jan; 32(1):109-14. PubMed ID: 16874466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.